Literature DB >> 19328994

Universal voluntary HIV testing and immediate antiretroviral therapy.

Allison Ruark, James D Shelton, Daniel T Halperin, Maria J Wawer, Ronald H Gray.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19328994     DOI： 10.1016/S0140-6736(09)60642-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Is the elimination of HIV infection within reach in the United States? Lessons from an epidemiologic transmission model.

Authors:  David R Holtgrave
Journal:  Public Health Rep       Date:  2010 May-Jun       Impact factor: 2.792

2.  The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study.

Authors:  Kimberly A Powers; Azra C Ghani; William C Miller; Irving F Hoffman; Audrey E Pettifor; Gift Kamanga; Francis Ea Martinson; Myron S Cohen
Journal:  Lancet       Date:  2011-07-16       Impact factor: 79.321

3.  Projecting the benefits of antiretroviral therapy for HIV prevention: the impact of population mobility and linkage to care.

Authors:  Jason R Andrews; Robin Wood; Linda-Gail Bekker; Keren Middelkoop; Rochelle P Walensky
Journal:  J Infect Dis       Date:  2012-06-18       Impact factor: 5.226

4.  Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.

Authors:  Peter J Dodd; Geoff P Garnett; Timothy B Hallett
Journal:  AIDS       Date:  2010-03-13       Impact factor: 4.177

5.  Understanding the relationship between couple dynamics and engagement with HIV care services: insights from a qualitative study in Eastern and Southern Africa.

Authors:  Joyce Wamoyi; Jenny Renju; Mosa Moshabela; Estelle McLean; Daniel Nyato; Doris Mbata; Oliver Bonnington; Janet Seeley; Kathryn Church; Basia Zaba; Alison Wringe
Journal:  Sex Transm Infect       Date:  2017-07       Impact factor: 3.519

Review 6.  The detection and management of early HIV infection: a clinical and public health emergency.

Authors:  M Kumi Smith; Sarah E Rutstein; Kimberly A Powers; Sarah Fidler; William C Miller; Joseph J Eron; Myron S Cohen
Journal:  J Acquir Immune Defic Syndr       Date:  2013-07       Impact factor: 3.731

Review 7.  Modelling sexual transmission of HIV: testing the assumptions, validating the predictions.

Authors:  Rebecca F Baggaley; Christophe Fraser
Journal:  Curr Opin HIV AIDS       Date:  2010-07       Impact factor: 4.283

8.  Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study.

Authors:  Brooke E Nichols; Charles A B Boucher; Janneke H van Dijk; Phil E Thuma; Jan L Nouwen; Rob Baltussen; Janneke van de Wijgert; Peter M A Sloot; David A M C van de Vijver
Journal:  PLoS One       Date:  2013-03-18       Impact factor: 3.240

9.  Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community.

Authors:  Ramzi A Alsallaq; Jared M Baeten; Connie L Celum; James P Hughes; Laith J Abu-Raddad; Ruanne V Barnabas; Timothy B Hallett
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

10.  Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study.

Authors:  Brooke E Nichols; Kim C E Sigaloff; Cissy Kityo; Raph L Hamers; Rob Baltussen; Silvia Bertagnolio; Michael R Jordan; Timothy B Hallett; Charles A B Boucher; Tobias F Rinke de Wit; David A M C van de Vijver
Journal:  J Int AIDS Soc       Date:  2014-12-05       Impact factor: 5.396
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.